| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AI helps doctors detect diseases more accurately and faster from medical images, improving patient care. |
Computer-aided diagnosis uses AI to reduce human error and support medical decisions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI acts as a second opinion by assisting radiologists in reviewing images, which helps reduce errors and improve diagnosis accuracy. |
This follows the concept of computer-aided diagnosis, where AI supports human decision-making to enhance reliability. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy means having basic understanding and knowledge about how AI works and its applications, enabling informed use and decision-making. |
Based on the concept of digital literacy, AI literacy empowers users to interact effectively with AI technologies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of AI machines is irrelevant to healthcare professionals’ acceptance; key factors involve trust, integration, understanding, and openness to technology. |
Technology Acceptance Model (TAM) emphasizes perceived usefulness and ease of use, not superficial features like color. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence impacts how healthcare professionals decide to adopt AI based on peers, leaders, and social norms. |
This is supported by the Unified Theory of Acceptance and Use of Technology (UTAUT), highlighting social influence on technology adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A common perceived threat is that AI might replace healthcare professionals, causing job insecurity and resistance to adoption. |
Based on Technology Acceptance Model, perceived threats affect users’ willingness to accept new technologies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Human-centred AI designs focus on usability and collaboration with healthcare professionals, increasing trust and acceptance. |
User-centred design principles highlight the importance of aligning technology with user needs to improve adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
System usage includes how well AI fits into existing workflows and the value it provides to users, influencing acceptance. |
Technology Acceptance Model highlights perceived usefulness and ease of integration as key to adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality influences whether healthcare professionals accept AI based on how well it aligns with their professional and moral values. |
Ethical Acceptance Theory emphasizes the role of value congruence in technology adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Future studies should focus on how users interact with AI and how well AI integrates into healthcare workflows to improve acceptance. |
User-Centred Design and Technology Acceptance Model stress the importance of user experience and system fit. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Human embryonic stem cells can differentiate into dopamine-producing neurons, which are lost in Parkinson’s disease, helping restore brain function. |
Stem cell therapy aims to replace damaged cells to restore normal function. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Monkeys are used because their brain structure and function closely resemble humans, making them ideal for testing safety and efficacy. |
Non-human primate models provide relevant insights into human neurological diseases and treatment responses. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
12 months |
|
A 12-month preclinical study in rats provides sufficient time to observe long-term safety and potential side effects. |
Long-term animal studies are essential for evaluating chronic toxicity before clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Phase I/IIa trials assess both safety (Phase I) and preliminary efficacy (Phase IIa) in a small group of patients. |
Early clinical trial phases combine safety and initial effectiveness evaluation before larger studies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
Manufacturing under GMP-compliant conditions ensures quality, safety, and regulatory compliance for clinical use. |
Good Manufacturing Practice (GMP) standards are essential for producing safe and effective medical products. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The absence of adverse effects and tumor formation in rats indicates the product’s safety for further development. |
Preclinical safety studies focus on detecting toxicity and tumorigenicity before clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The transplanted stem cells successfully restored motor function, showing potential therapeutic effect for Parkinson’s disease. |
Stem cell therapy aims to replace lost neurons and improve functional deficits in neurodegenerative diseases. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
GIRK2 and ALDH1A1 are specific markers for mature dopamine neurons, indicating the purity of the stem cell batch. |
Using cell-type specific markers ensures the quality and identity of differentiated cells in stem cell therapy. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
FGF8b and SHH are growth factors that guide stem cells to develop into specific types of neurons by influencing cell patterning. |
Developmental biology shows these factors regulate neural differentiation and regional identity. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
Recovery of motor function indicates that the treatment helped repair neurological damage caused by Parkinson’s disease in rats. |
Recovery of motor function indicates that the treatment helped repair neurological damage caused by Parkinson’s disease in rats. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|